Factors Affecting Transfusion Utilization in Acute Myeloid Leukemia (AML) Patients Undergoing Initial Therapy
Sang‐Min Lee(Kyungpook National University), Melissa M. Cushing(NewYork–Presbyterian Hospital), Idongessit Udoyen(Cornell University), Kartikey Grover(Cornell University), Kathleen Kane(NewYork–Presbyterian Hospital), Priscilla Parra(Cornell University), Pinkal Desai(NewYork–Presbyterian Hospital), Ellen K. Ritchie(Cornell University), Michael Samuel(NewYork–Presbyterian Hospital), Gail J. Roboz(Cornell University)
Cited by 1
Related Papers
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k